Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com admin Website Prev Post Maiden Drill Program Commences at Oasis Uranium Project July 28, 2025 Next Post GTI Energy July 28, 2025 Related Posts Flow Metals Announces Closing of Shares for Debt January 31, 2026 Forte Minerals Corp. Amendment to Investor Relations Compensation January 31, 2026 Is it Time to Take Profits? Experts Share Gold and Silver Strategies in Vancouver January 31, 2026